Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

AGORA

Financiado

Cerrado

ATMP GMP Open Access Research Alliance AGORA

We propose an academic & industrial partnership to facilitate safe and effective delivery of new advanced therapy medicines within the framework of the relevant EU regulations which our previous FP7 funded project have identified... ver más

31/10/2015

UNIVERSITY COLLEGE...

555K€

Presupuesto del proyecto: 555K€

Líder del proyecto

UNIVERSITY COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 8 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-10-31 No tenemos la información de la convocatoria

0% 90% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

UNIVERSITY COLLEGE LONDON

180.82K€ | Lider

MHH

45.37K€ | Participante

UMC UTRECHT

63.13K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ACADEMIC GMP The impact of Regulation EC No 1394 2007 on the developmen... 558K€ Cerrado

JOIN4ATMP MAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY... 3M€ Cerrado

PID2019-105597RA-I00 COSTE EFECTICTIVIDAD DE PRODUCTOS MEDICOS DE TERAPIAS AVANZA... 21K€ Cerrado

C-stemGMP c GMP compliance of C stem an IPSc based cell therapies pro... 3M€ Cerrado

EQC2019-005948-P Unidad para investigación y desarrollo en terapia celular av... 143K€ Cerrado

CREATIC Central European Advanced Therapy and Immunotherapy Centre 15M€ Cerrado

Líder del proyecto

UNIVERSITY COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 555K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto We propose an academic & industrial partnership to facilitate safe and effective delivery of new advanced therapy medicines within the framework of the relevant EU regulations which our previous FP7 funded project have identified as creating unanticipated barriers to development of this field. Over 80% of advanced therapy medicines (ATMPs) trials in the EU are academic investigator led and sponsored. Many ATMPs are not making it to first-in-man trials due to the difficulties of academic manufacture to GMP compliance and the variation of application of the Directives between EU MS. We will deliver a supporting programme of resources to academic trialists to streamline their development programmes, enhance compliance with GMP requirements, develop industrial partnerships for improved manufacture and scale-up and establish the first university certified training programmes in cell/tissue engineering to address the critical shortage in scientific/technical/regulatory staff in this newly expanding field across the EU. The future supply of successful ATMPs to EU citizens will require partnerships between academic GMP facilities, contract ATMP manufacturers (CMOs) and the biopharma industry and this project will deliver the necessary support and training structure to create this partnership. The need for this project has been identified from the impact assessment part of our current FP7 project, Academic GMP and the culmination of the project will be a scientific analysis of the effect of the programme on the impact of the legislation relevant to ATMP development and provision across the EU.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores